Development and Validation of a Rapid Turbidimetric Assay to Determine the Potency of Cefuroxime Sodium in Powder for Dissolution for Injection

Development and Validation of a Rapid Turbidimetric Assay to Determine the Potency of Cefuroxime Sodium in Powder for Dissolution for Injection

The cefuroxime sodium is a second generation cephalosporin indicated for infections caused by Gram-positive and Gram-negative microorganisms. Although this drug is highly studied and researched regarding the antimicrobial activity, pharmacokinetics and pharmacodynamics, there are few studies regardi...

Full description

Bibliographic Details
Main Authors:	Daniela C. M. Vieira, Thalita F. M. Fiuza, Hérida R.N. Salgado
Format:	Article
Language:	English
Published:	MDPI AG 2014-07-01
Series:	Pathogens
Subjects:	cefuroxime sodium microbiological testing quality control validation and stability
Online Access:	http://www.mdpi.com/2076-0817/3/3/656

Similar Items

Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder
by: Eliane Gandolpho Tótoli, et al.
Published: (2015-07-01)

Effect of Intracameral Cefuroxime Injection in Prophylaxis of Postoperative Endophthalmitis
by: Hassan Razmju, et al.
Published: (2011-03-01)

Effects of intracameral cefuroxime injection on the prophylaxis of endophthalmitis after cataract surgeries: a Meta-analysis
by: Xiao-Yu Wu, et al.
Published: (2015-10-01)

Evaluation of intracameral cefuroxime injection for endophthalmitis prophylaxis following phacoemulsification
by: Ze-Bin Li, et al.
Published: (2018-12-01)

QUANTUM MECHANICAL CALCULATIONS OF IR SPECTRA; REACTION ENERGIES OF C-O (R-O) THERMAL BOND RUPTURE FOR CEFUROXIME PRODRUGS
by: REHAB MAJED KUBBA, et al.
Published: (2013-08-01)

Development of Retinal Infarct Due to Intracameral Cefuroxime Injection Following Complicated Cataract Surgery
by: Sabahattin Sül, et al.
Published: (2018-12-01)

Cefuroxime axetil induced DRESS in a pregnant patient
by: Aruna Singh, et al.
Published: (2023-08-01)

In vitro Analysis of Antimicrobial Properties of Cefuroxime Impregnated Bone Cement
by: A Suhail, et al.
Published: (2008-11-01)

Effect of Intracameral Ophthalmic Cefuroxime Solution (Aprokam®) in the Prophylaxis of Cataract Surgery in Patients with Keratoplasty
by: Mustafa Erdoğan Cicik, et al.
Published: (2018-03-01)

Computer-Aided Design of Cefuroxime Axetil/Cyclodextrin System with Enhanced Solubility and Antimicrobial Activity
by: Mikołaj Mizera, et al.
Published: (2019-12-01)

Intracameral cefuroxime in combined pars plana vitrectomy and phacoemulsification: a study of safety
by: Besozzi G, et al.
Published: (2018-08-01)

Study of Kinetics of degradation of cefuroxime axetil in acetone solution
by: Zhefan ZHANG, et al.
Published: (2020-08-01)

Cefuroxime axetil loaded gastroretentive floating tabletsbased on hydrophilic polymers: preparation and in vitro evaluation
by: Snehamayee Mohapatra, et al.
Published: (2012-04-01)

Preparation and characterization of cefuroxime axetil solid dispersions using poloxamer 188
by: Thaeer Sankari, et al.
Published: (2019-04-01)

Development and validation of a rapid turbidimetric assay to determine the potency of norfloxacin in tablets
by: Lucas Chierentin, et al.
Published: (2015-09-01)

Intraoperative Cefuroxime Irrigation Prophylaxis for Acute-Onset Endophthalmitis After Phacoemulsification Surgery
by: Ma X, et al.
Published: (2020-05-01)

Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime
by: Simona Sapino, et al.
Published: (2019-10-01)

Comparison of Cefuroxim versus Cefotaxim in the Treatment of Pneumonia in Children Aged 3 Months- 5 Years an Imaging and Clinical Examination Evidence: Randomized Controlled Trial.
by: Hashem Mohammed Mansour, et al.
Published: (2014-09-01)

Meta-Analysis of Clinical Trials Comparing Cefazolin to Cefuroxime, Ceftriaxone, and Cefamandole for Surgical Site Infection Prevention
by: Nehad J. Ahmed, et al.
Published: (2022-11-01)

Physicochemical Characterization and Antimicrobial Activity of Mechanochemically and Solvent-Based Synthesized Mn(II) Complexes of Cefixime and Cefuroxime
by: Aisha Makinta, et al.
Published: (2022-08-01)

The Impact of Antimicrobial Stewardship Program on Injudicious Use of Cefuroxime
by: Ann L. Arulappen, et al.
Published: (2021-02-01)

Stevens–Johnson syndrome/toxic epidermal necrolysis overlap syndrome due to oral cefuroxime
by: D Prabath Kumar, et al.
Published: (2019-01-01)

Development, characterization and solubility study of solid dispersions of cefuroxime axetil by the solvent evaporation method
by: S C Arora, et al.
Published: (2010-01-01)

Antirheumatoid arthritis and cellular uptake study of cefuroxime axetil-loaded boswellic acids nanoparticles on RAW 264.7 cells
by: Gitika Rani, et al.
Published: (2023-10-01)

Thermosensitive Intravitreal In Situ Implant of Cefuroxime Based on Poloxamer 407 and Hyaluronic Acid
by: Elena O. Bakhrushina, et al.
Published: (2023-08-01)

Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics
by: Harun SN, et al.
Published: (2018-04-01)

Electrospun PCL/cefuroxime scaffolds with custom tailored topography
by: Emilija Zdraveva, et al.
Published: (2019-01-01)

Poly(ε-caprolactone) Titanium Dioxide and Cefuroxime Antimicrobial Scaffolds for Cultivation of Human Limbal Stem Cells
by: Mirna Tominac Trcin, et al.
Published: (2020-08-01)

Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
by: Zhiqiang Song, et al.
Published: (2019-07-01)

Development and Validation of a Successful Microbiological Agar Assay for Determination of Ceftriaxone Sodium in Powder for Injectable Solution
by: Patrícia V. Aléssio, et al.
Published: (2012-06-01)

Design, synthesis, characterization, antimicrobial activity, cytotoxicity, molecular docking, and in-silico ADMET analysis of the novel cefuroxime derivatives
by: Ananta Kumar Das, et al.
Published: (2024-04-01)

USE OF ESCHERICHIA COLI K-12 STRAIN WITH GFP REPORTER GENE FOR SCREENING OF CEFUROXIME AND METRONIDAZOLE RESIDUES IN SURFACE WATER
by: Marzena Matejczyk, et al.
Published: (2015-06-01)

Formulation of cefuroxime axetil oral suspension and investigation of its pharmaceutical properties
by: Hadi Valizadeh, et al.
Published: (2011-12-01)

Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase
by: Serena Sagliocchi, et al.
Published: (2023-03-01)

High Cefuroxime Concentrations and Long Elimination in an Orthopaedic Surgical Deadspace—A Microdialysis Porcine Study
by: Sara Kousgaard Tøstesen, et al.
Published: (2022-02-01)

<it>Clostridium difficile</it> 027-associated pseudomembranous colitis after short-term treatment with cefuroxime and cephalexin in an elderly orthopedic patient: a case report
by: Søgaard Kirstine, et al.
Published: (2012-10-01)

Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation
by: Sarika Sapte, et al.
Published: (2016-10-01)

Effect of Inappropriate Treatment in Hospitalized Patients with Pyelonephritis Treated with Cefuroxime: A Cohort Study
by: Jorge Alberto Cortés, et al.
Published: (2024-03-01)

Effect of low-concentration vancomycin injection in the anterior chamber for prevention of infectious endophthalmitis after cataract surgery
by: TAO Li, et al.
Published: (2020-10-01)

Optimization of a Cefuroxime Axetil-Loaded Liquid Self-Nanoemulsifying Drug Delivery System: Enhanced Solubility, Dissolution and Caco-2 Cell Uptake
by: Arshad Ali Khan, et al.
Published: (2022-04-01)